Cargando…

Ph-Negative Chronic Myeloproliferative Neoplasm (Primary Myelofibrosis) – as One of the Reasons of the Budd-Chiari Syndrome

Detalles Bibliográficos
Autores principales:	Sokolova, M., Tsvetaeva, N., Sukhanova, G., Vasiliev, S., Misurin, A., Sanatko, M., Nareiko, M., Rudakova, V., Semenova, E., Khoroshko, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2012
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395678/ https://www.ncbi.nlm.nih.gov/pubmed/22811796 http://dx.doi.org/10.4084/MJHID.2012.047

Ejemplares similares

Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2023)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
por: Li, Bing, et al.
Publicado: (2017)

Review of Budd-Chiari Syndrome
por: Zu, Maoheng, et al.
Publicado: (2020)

Histopathology of Budd–Chiari Syndrome
por: Quaglia, Alberto
Publicado: (2023)

Behcet’s disease in budd-chiari syndrome
por: Desbois, Anne Claire, et al.
Publicado: (2014)

Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis
por: Barosi, Giovanni, et al.
Publicado: (2015)

Budd-Chiari Syndrome: Shunt or Transplant?
por: Orloff, Marshall J.
Publicado: (1998)

Budd-Chiari Syndrome: Shunt or Transplant?
por: McMaster, Paul
Publicado: (1994)

Budd–Chiari Syndrome: an unnoticed diagnosis
por: Falcão, Camila Kruschewsky, et al.
Publicado: (2015)

Diagnosis and therapy of Budd Chiari syndrome
por: Lupasco, Iulianna, et al.
Publicado: (2021)

Budd-Chiari-like pathology in dolphins
por: Fernandez, Antonio, et al.
Publicado: (2022)

Interventional Treatment of Budd–Chiari Syndrome
por: Rössle, Martin
Publicado: (2023)

Small hepatic veins Budd–Chiari syndrome
por: Riggio, Oliviero, et al.
Publicado: (2013)

Budd-Chiari syndrome mimicking autoimmune hepatitis
por: Bova, Carlo, et al.
Publicado: (2023)

Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms
por: Benedetti, Edoardo, et al.
Publicado: (2020)

Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
por: Talpaz, Moshe, et al.
Publicado: (2020)

Budd-Chiari syndrome in a patient of diabetic ketoacidosis
por: Dasgupta, Arundhati, et al.
Publicado: (2012)

Budd-Chiari Syndrome: Two Cases with Different Courses
por: Inomata, Shinjiro, et al.
Publicado: (2008)

Colon Perforation and Budd-Chiari Syndrome in Behçet’s Disease
por: Baş, Yılmaz, et al.
Publicado: (2015)

Budd-Chiari syndrome with multiple large regenerative nodules
por: Kim, Haeryoung, et al.
Publicado: (2015)

Budd-Chiari Syndrome: An Unusual Presentation of Multisystemic Sarcoidosis
por: Ennaifer, Rym, et al.
Publicado: (2015)

Budd-Chiari Syndrome in a Patient with Hepatitis C
por: Frankl, Joseph, et al.
Publicado: (2016)

Liver cirrhosis caused by chronic Budd–Chiari syndrome
por: Lin, Mengjie, et al.
Publicado: (2017)

Outcomes of pregnancy in patients with known Budd-Chiari syndrome
por: Khan, Faisal, et al.
Publicado: (2017)

Budd-Chiari syndrome presenting with abdominal wall varices
por: Yang, Hee Chan, et al.
Publicado: (2020)

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
por: Tiryaki, Tarık Onur, et al.
Publicado: (2020)

Experts consensus on Chinese nomenclature of Budd-Chiari syndrome
por: Zu, Maoheng, et al.
Publicado: (2021)

The application and efficacy of stent place for Budd-Chiari syndrome
por: Zu, Maoheng, et al.
Publicado: (2019)

Budd-Chiari primitif: défi diagnostique et thérapeutique
por: Benali, Fatimaezzahra, et al.
Publicado: (2020)

Budd–Chiari Syndrome Management: Controversies and Open Issues
por: Mancuso, Andrea
Publicado: (2022)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
por: Yacoub, A., et al.
Publicado: (2014)

TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche
por: Yao, Juo-Chin, et al.
Publicado: (2022)

Acute Budd–Chiari syndrome due to a simple liver cyst
por: Long, J, et al.
Publicado: (2014)

Pregnancy in Budd-Chiari Syndrome: Case Report and Proposed Risk Score
por: Merz, Waltraut M., et al.
Publicado: (2016)

Fulminant Presentation of Budd-Chiari Syndrome Secondary to COVID-19 Infection
por: Sanekommu, Harshavardhan, et al.
Publicado: (2023)

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
por: Ianotto, Jean-Christophe, et al.
Publicado: (2018)

Treatment of Budd-Chiari syndrome with inferior vena cava thrombosis
por: WANG, RUIHUA, et al.
Publicado: (2013)

A Case of Budd-Chiari Syndrome Associated with Alveolar Echinococcosis
por: Çakmak, Erol, et al.
Publicado: (2013)

Rapidly Progressing Budd-Chiari Syndrome Complicated by Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_rf4he30bhsdk8grf9tmcebutju